维普期刊资源整合服务平台（V6.5）

56篇 您的检索式：作者名="HOLEN I"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Anti-tumour effects of bisphosphonates--what have we learned from in vivo models? 显示文摘	Brown H K Holen I	2009	Curr Cancer Drug Targets2009，9，7：	1
2	Role of osteoprotegerin(OPG) in cancer显示文摘	Holen I Shipman CM	2006	Clin Sd (Lond)2006，110，3：	1
3	Evidence of a role for a non-matrix-type metalloproteinase activity in the shedding of syndecan-1 from human myeloma cells 显示文摘	Holen I Drury N L Hargreaves P G	2001	Br J Haematol2001，114，2：	1
4	Serum osteoprotegerin (OPG)levels are associated with disease progression and response to androgen ablation in patients with prostate cancer显示文摘	Eaton CL Wells JM Holen I	2004	Prostate2004，59，3：	1
5	Anti-tumour effects of bisphosphonates-what have we learned from in vivo models显示文摘	Brown HK Holen I	2009	? Curt Cancer Drug Targets2009，9，7：	1
6	Exploring the anti-tumour activity of bisphosphonates in early breast cancer显示文摘	Winter MC Holen I Coleman RE	2008	Cancer Treat Rev2008，34，5：	1
7	Protein kinasedependent effects of okadaic acid on hepatocytic autophagy and cytoskeletal integrity显示文摘	HOLEN I GORDON P B SEGLEN P O	1992	Biochem1992，284，3：	1
8	Multidrug resistance in breast cancer: from in vitro models to clinical studies 显示文摘	Wind NS Holen I	2012	Int J Breast Cancer2012，2011，96：	1
9	Tumour macrophages as potential targets of bisphosphonates显示文摘	Rogers TL Holen I		0，，：	1
10	Expression and activity of ADAMTS-5 in synovium显示文摘	Vankemmelbeke MN Holen I Wilson AG	2001	Eur J Biochem2001，268，：	1
11	The anti-tumour activity of bisphosphonates显示文摘	Neville-Webbe HL Holen I Coleman RE	2002	Cancer Treat Rev2002，28，6：	1
12	Exploring the anti- tumour activity of bisphosphonates in early breast canc- er显示文摘	Winter M Holen I Coleman R	2008	Cancer treatment reviews2008，34，5：	1
13	Tumour maerophages as potential targets of bisphosphonates显示文摘	Rogers TL Holen I	2011	J Transl Med2011，9，：	1
14	Osteoprotegerin induces cytoskeletal reorganization and activates FAN, Src, and ERK signaling in endothelial cells显示文摘	Kobayashi-Sakamoto M Isogai E Holen I	2010	Eur J Haematol2010，85，1：	1
15	Multidrug resistance in breast cancer:from in vitro models to clinical studies显示文摘	WIND NS HOLEN I		0，，：	1
16	Tumour macrophages as potential targets of bisphosphonates 显示文摘	Rogers TL Holen I	2011	J Transl Med2011，9，：	1
17	Optimizing the yield and utility of circulating cell -free DNA from plasma and ser- um显示文摘	Xue X Teare MD Holen I	2009	Clin Chim Acta2009，404，2：	1
18	Pathophysiological roles of osteoprotegerin (OPG) 显示文摘	Reid P Holen I	2008	Eur J Cell Biol2008，，：	1
19	The anti-tumor activity of bisophosnates显示文摘	Neville-Webbe HL Holen I Coleman RE	2002	Cancer Treat Rev2002，28，6：	1
20	Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells 显示文摘	Holen I Croucher P I Hamdy F C	2002	Cancer Res2002，62，6：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示